# Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis

Study · id `cardio:ct-nct01475799` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01475799](<https://clinicaltrials.gov/study/NCT01475799>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01475799

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 112 participants.

## Technical summary

Registry record NCT01475799. Allocation not applicable; no masking; primary purpose treatment. Start 2011-11 (registry gives no type); primary completion 2014-07 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 112 participants (enrolled count; ClinicalTrials.gov record NCT01475799, source copy `cardio:ctgov-nct01475799-2016-11-01`, retrieved 2026-10-26)
- Start date: 2011-11 (registry gives no type) (ClinicalTrials.gov record NCT01475799, source copy `cardio:ctgov-nct01475799-2016-11-01`, retrieved 2026-10-26)
- Primary completion: 2014-07 (actual) (ClinicalTrials.gov record NCT01475799, source copy `cardio:ctgov-nct01475799-2016-11-01`, retrieved 2026-10-26)
- Completion: 2019-07 (anticipated) (ClinicalTrials.gov record NCT01475799, source copy `cardio:ctgov-nct01475799-2016-11-01`, retrieved 2026-10-26)
- Countries: France; Germany; Italy; Luxembourg; United Kingdom (ClinicalTrials.gov record NCT01475799, source copy `cardio:ctgov-nct01475799-2016-11-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01475799-2016-11-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis
- Condition: Aortic Valve Stenosis
- Intervention (Device): Replacement of the Aortic Stenotic Valve
- Lead sponsor: Direct Flow Medical, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)

## Provenance

Content hash: cb15b3a6ad83cdaca3c2b22597b3ac0c6d0ea4bd7e0a246de6a129063c76e1fb
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
